Literature DB >> 26878971

Murine immunization with CS21 pili or LngA major subunit of enterotoxigenic Escherichia coli (ETEC) elicits systemic and mucosal immune responses and inhibits ETEC gut colonization.

Chengxian Zhang1, Junaid Iqbal1, Oscar G Gómez-Duarte2.   

Abstract

CS21 pili of enterotoxigenic Escherichia coli (ETEC) is one of the most prevalent ETEC colonization factors. CS21 major subunit, LngA, mediates ETEC adherence to intestinal cells, and contributes to ETEC pathogenesis in a neonatal mouse infection model. The objectives of this work were to evaluate LngA major subunit purified protein and CS21 purified pili on immunogenicity and protection against ETEC colonization of mice intestine. Recombinant LngA purified protein or purified CS21 pili from E9034A ETEC strain were evaluated for immunogenicity after immunization of C57BL/6 mice. Specific anti-LngA antibodies were detected from mice serum, feces, and intestine fluid samples by ELISA assays. Protection against gut colonization was evaluated on immunized mice orally challenged with wild type E9034A ETEC strain and by subsequent quantification of bacterial colony forming units (CFU) recovered from feces. Recombinant LngA protein and CS21 pili induced specific humoral and mucosal anti-LngA antibodies in the mouse model. CS21 combined with CT delivered intranasally as well as LngA combined with incomplete Freund adjuvant delivered intraperitoneally inhibited ETEC gut colonization in a mouse model. In conclusion, both LngA purified protein and CS21 pili from ETEC are highly immunogenic and may inhibit ETEC intestinal shedding. Our data on immunogenicity and immunoprotection indicates that CS21 is a suitable vaccine candidate for a future multivalent vaccine against ETEC diarrhea.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CS21; Colonization; Enterotoxigenic Escherichia coli (ETEC); LngA; Mucosal immunity; Type IV pili; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 26878971      PMCID: PMC4976044          DOI: 10.1016/j.vetmic.2016.02.001

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  46 in total

1.  Longus, a type IV pilus of enterotoxigenic Escherichia coli, is involved in adherence to intestinal epithelial cells.

Authors:  Karina Mazariego-Espinosa; Ariadnna Cruz; Maria A Ledesma; Sara A Ochoa; Juan Xicohtencatl-Cortes
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

2.  Enterotoxigenic Escherichia coli CS21 pilus contributes to adhesion to intestinal cells and to pathogenesis under in vivo conditions.

Authors:  C P Guevara; W B Luiz; A Sierra; C Cruz; F Qadri; R S Kaushik; L C S Ferreira; O G Gómez-Duarte
Journal:  Microbiology       Date:  2013-06-12       Impact factor: 2.777

3.  New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites.

Authors:  J M Parker; D Guo; R S Hodges
Journal:  Biochemistry       Date:  1986-09-23       Impact factor: 3.162

4.  Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model.

Authors:  Koushik Roy; David Hamilton; Marguerite M Ostmann; James M Fleckenstein
Journal:  Vaccine       Date:  2009-06-11       Impact factor: 3.641

Review 5.  Implications of enterotoxigenic Escherichia coli genomics for vaccine development.

Authors:  Åsa Sjöling; Astrid von Mentzer; Ann-Mari Svennerholm
Journal:  Expert Rev Vaccines       Date:  2014-12-26       Impact factor: 5.217

Review 6.  Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.

Authors:  Firdausi Qadri; Ann-Mari Svennerholm; A S G Faruque; R Bradley Sack
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

7.  Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR.

Authors:  Cara E Morin; James B Kaper
Journal:  FEMS Immunol Med Microbiol       Date:  2009-07-01

8.  Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

Authors:  E A Emini; J V Hughes; D S Perlow; J Boger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.

Authors:  J Holmgren; L Bourgeois; N Carlin; J Clements; B Gustafsson; A Lundgren; E Nygren; J Tobias; R Walker; A-M Svennerholm
Journal:  Vaccine       Date:  2013-03-27       Impact factor: 3.641

10.  Molecular characterization of Enterotoxigenic Escherichia coli strains isolated from diarrheal patients in Korea during 2003-2011.

Authors:  Kyung-Hwan Oh; Dong Wook Kim; Su-Mi Jung; Seung-Hak Cho
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

View more
  4 in total

1.  In silico Designing of an Epitope-Based Vaccine Against Common E. coli Pathotypes.

Authors:  Mohamed A Soltan; Mohammed Y Behairy; Mennatallah S Abdelkader; Sarah Albogami; Eman Fayad; Refaat A Eid; Khaled M Darwish; Sameh S Elhady; Ahmed M Lotfy; Muhammad Alaa Eldeen
Journal:  Front Med (Lausanne)       Date:  2022-03-04

Review 2.  Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development.

Authors:  Maricarmen Rojas-Lopez; Ricardo Monterio; Mariagrazia Pizza; Mickaël Desvaux; Roberto Rosini
Journal:  Front Microbiol       Date:  2018-03-20       Impact factor: 5.640

3.  Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN-Mannosamine Polymer Conjugate.

Authors:  Melibea Berzosa; Alzbeta Nemeskalova; Alba Calvo; Gemma Quincoces; María Collantes; Felix Pareja; Carlos Gamazo; Juan Manuel Irache
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

4.  Effects of IQW and IRW on Inflammation and Gut Microbiota in ETEC-Induced Diarrhea.

Authors:  Naiyuan Liu; Lingsi Zhou; Jun Fang; Hongmei Jiang; Gang Liu
Journal:  Mediators Inflamm       Date:  2021-09-23       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.